These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 514426)

  • 1. Peritoneal transport of vancomycin during peritoneal dialysis.
    Nielsen HE; Sørensen I; Hansen HE
    Nephron; 1979; 24(6):274-7. PubMed ID: 514426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
    Mounier M; Benevent D; Denis F
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):542-4. PubMed ID: 3911152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous vancomycin as initial treatment for gram-positive peritonitis in patients on chronic peritoneal dialysis.
    Obermiller LE; Tzamaloukas AH; Leymon P; Avasthi PS
    Clin Nephrol; 1985 Nov; 24(5):256-60. PubMed ID: 3907908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis.
    Ayus JC; Eneas JF; Tong TG; Benowitz NL; Schoenfeld PY; Hadley KL; Becker CE; Humphreys MH
    Clin Nephrol; 1979 Mar; 11(3):129-32. PubMed ID: 436339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of serum vancomycin concentrations following intraperitoneal loading doses in continuous ambulatory peritoneal dialysis patients with peritonitis.
    Bailie GR; Eisele G; Venezia RA; Yocum D; Hollister A
    Clin Pharmacokinet; 1992 Apr; 22(4):298-307. PubMed ID: 1606789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal urokinase and oral rifampicin for persisting asymptomatic dialysate infection following acute coagulase-negative staphylococcus peritonitis.
    Demoulin N; Goffin E
    Perit Dial Int; 2009; 29(5):548-53. PubMed ID: 19776049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of intravenous vancomycin in the treatment of gram-positive peritonitis in long-term peritoneal dialysis.
    Krothapalli RK; Senekjian HO; Ayus JC
    Am J Med; 1983 Aug; 75(2):345-8. PubMed ID: 6881188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis.
    Pancorbo S; Comty C
    Nephron; 1982; 31(1):37-9. PubMed ID: 7110474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should cefazolin or vancomycin be used for initial empiric coverage for Staphylococcus aureus in peritoneal dialysis associated peritonitis?
    Hansson JH
    Semin Dial; 2011; 24(4):449-50. PubMed ID: 21851410
    [No Abstract]   [Full Text] [Related]  

  • 10. Vancomycin pharmacokinetics in patients undergoing chronic intermittent peritoneal dialysis.
    Glew RH; Pavuk RA; Shuster A; Alfred HJ
    Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):559-63. PubMed ID: 7152738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis.
    Harford AM; Sica DA; Tartaglione T; Polk RE; Dalton HP; Poynor W
    Nephron; 1986; 43(3):217-22. PubMed ID: 3724930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin disposition following intraperitoneal administration in children receiving peritoneal dialysis.
    Blowey DL; Warady BA; Abdel-Rahman S; Frye RF; Manley HJ
    Perit Dial Int; 2007; 27(1):79-85. PubMed ID: 17179516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis.
    Neal D; Bailie GR
    Clin Pharmacokinet; 1990 Jun; 18(6):485-90. PubMed ID: 2354591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of single dose intravenous vancomycin in CAPD peritonitis.
    Whitby M; Edwards R; Aston E; Finch RG
    J Antimicrob Chemother; 1987 Mar; 19(3):351-7. PubMed ID: 3571051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe eosinophilic peritonitis caused by intraperitoneal vancomycin administration.
    Hsu CY; Lee DJ; Lin SH
    Clin Nephrol; 2021 Sep; 96(3):184-187. PubMed ID: 34042582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis.
    Blevins RD; Halstenson CE; Salem NG; Matzke GR
    Antimicrob Agents Chemother; 1984 May; 25(5):603-6. PubMed ID: 6732227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritonitis in children with automated peritoneal dialysis: a single-center study of a 10-year experience.
    Dotis J; Myserlis P; Printza N; Stabouli S; Gkogka C; Pavlaki A; Papachristou F
    Ren Fail; 2016 Aug; 38(7):1031-5. PubMed ID: 27185324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gentamicin removal during intermittent peritoneal dialysis.
    Indraprasit S; Ukaravichien V; Pummangura C; Kaojarern S
    Nephron; 1986; 44(1):18-21. PubMed ID: 3748247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of gram-positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis patients.
    Bastani B; Freer K; Read D; Bailey S; Sherman RA; Davis M; Engels D; Westervelt FB
    Nephron; 1987; 45(4):283-5. PubMed ID: 3587467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial treatment of dialysis associated peritonitis: a controlled trial of vancomycin versus cefazolin.
    Flanigan MJ; Lim VS
    Perit Dial Int; 1991; 11(1):31-7. PubMed ID: 2049420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.